SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Youngevity International Inc., a global direct marketer of nutritional and lifestyle products and producer of gourmet coffees, has raised $5 million in equity and debt financing, according to a recent filing with the Securities and Exchange Commission.January 27, 2015 3:56 p.m. Share
Mirati Therapeutics Inc., a company developing medicines for targeted oncology, announced the pricing of an underwritten public offering at $45 million.
Qualcomm Life Inc., the mobile health-focused subsidiary of Qualcomm Inc., announced a collaboration with the Roche Group to innovate remote monitoring and management of patients with chronic diseases.
San Diego-based BioNano Genomics Inc., a genome-mapping device company, has raised $68.5 million in financing, according to a recent filing with the Securities and Exchange Commission.
San Diego-based Illumina Inc. reported fourth-quarter net income of $153.3 million, or $1.03 per share, up from $80.7 million, or $0.56 per share, last year.
DexCom Inc., a San Diego-based medical device company, announced that it has received U.S. Food and Drug Administration approval for a continuous glucose-monitoring system with data-sharing capabilities.
Aspyrian Therapeutics Inc., a San Diego-based biotechnology startup, has raised $8.45 million in equity financing, according to a recent filing with the Securities and Exchange Commission.
President Obama’s State of the Union address Jan. 20 teased the federal launch of an initiative that could provide a huge financial boost to San Diego’s genomics industry.
Two San Diego companies, Cypher Genomics Inc. and Sequenom Inc., announced an agreement to further develop next-generation noninvasive prenatal tests.
HEALTH: Financing Should Help With U.S. Approval Process
The founding team of multibillion-dollar medical device maker DexCom Inc. is working on a new project that may offer an alternative to stomach-stapling surgeries.
MEDICINE: Kaiser Part Of National Pilot Project
Kaiser Permanente San Diego is testing a high-tech telehealth station that allows patients to see a doctor without ever leaving work.
TRACON Pharmaceuticals Inc., which is developing antibodies to treat cancer, age-related macular degeneration and fibrotic diseases, announced terms for its IPO.
ResMed Inc. reported fiscal second-quarter net income of $91.2 million on Thursday.
San Diego-based Otonomy Inc. has filed for a proposed follow-on public offering of $75 million of its common stock.
San Diego-based Trovagene Inc., a molecular diagnostics company, announced that it will expand the clinical collaboration with Genomac Research Institute in Prague, Czech Republic.